GSK's Mark Reilly to return to China shortly

Singapore: GlaxoSmithKline's former China head Mr Mark Reilly would be returning to China shortly to assist the police w...

July 29, 2013 | Monday | News
3SBio retains Gottlieb Steen & Hamilton as legal counsel

Singapore: 3SBio, a leading China-based biotechnology company focused on R&D, manufacturing and marketing biopharma...

September 18, 2012 | Tuesday | News
Mr Steven Kaufman, SHL Group: 2013 will be an exciting year for drug delivery devices

Pharmaceutical companies in the region are starting to take more interest in biologics and biosimilars, and of course wi...

December 25, 2012 | Tuesday | Opinion
China Cord Blood revenues up 57% to $24.0 mn

Singapore: China Cord Blood, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem c...

February 27, 2013 | Wednesday | Company results
Sanjiu Medical keeps focus on R&D

Sanjiu Medical and Pharmaceutical is a manufacturing and marketing company for medicines, healthcare products, and medic...

June 21, 2012 | Thursday | Analysis
GSK executives confessed to bribery charges: China

Singapore: Two weeks after intense investigations into GlaxoSmithKline's (GSK) operations across China, the country's se...

July 12, 2013 | Friday | News
J&J puts all Chinese units under single local chairman

Singapore: The business heads of Johnson & Johnson's (J&J) three Chinese operations would report to one local ch...

August 29, 2013 | Thursday | News
China develops revolutionary TCM migraine medication

Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...

July 18, 2012 | Wednesday | News
Can-Fite APIs to be manufactured by China CRO

Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF1...

January 24, 2013 | Thursday | News
X-Change to launch Phytiva in China, SE Asia

Singapore: X-Change, a US-based boutique company whose niche is extract-based cosmeceutical and nutraceutical solutions ...

January 28, 2013 | Monday | News
OrbusNeich launches dual therapy heart stent

Singapore: Hong Kong-based OrbusNeich has launched dual therapy stent to address the challenges of delayed healing of th...

May 29, 2013 | Wednesday | News
China vitamin C manufacturer fined by US court

Singapore: A US court has fined North China Pharmaceutical (NCPC), a vitamin C manufacturer and antibiotics supplier, $1...

March 20, 2013 | Wednesday | News
Daewoong buys China's Liaoning Baifeng for $20 mn

Singapore: Daewoong Pharmaceutical is going to acquire Liaoning Baifeng, a Shenyang (Liaoning Province)-based manufactur...

August 6, 2013 | Tuesday | News
Charles River grows $286 mn in Q1 2013

Singapore: Charles River Laboratories has reported an increase of 1.8 percent in first quarter of 2013, clocking $286.0 ...

May 2, 2013 | Thursday | Company results
Shenzhen Accord all set to go beyond China

China is undergoing healthcare reforms and, in the process, industry regulations are becoming strict. Adopting a new bus...

June 7, 2012 | Thursday | Analysis
India, China top 2013's GMP failures: EMA

Singapore: In a bid to bring about transparency, the European Medicines Agency (EMA) has released the public version of ...

January 9, 2014 | Thursday | News
Dehaier reports decrease in revenue in Q3'12

Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devic...

November 15, 2012 | Thursday | Company results
MedImmune, WuXi form joint venture

Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a research and development outsourcing c...

September 10, 2012 | Monday | News